Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)


Several different peptides and proteins, such as the pancreatic trypsin inhibitor, growth factors and trefoil peptides, are known to play important roles in maintaining the structure and function of the gastrointestinal wall. With the advent of recombinant biotechnology, it has become feasible to test some of these proteins as therapeutics in different inflammatory conditions of the intestines. However, the harsh pH and enzymatic conditions of the stomach can lead to their inactivation. This research was aimed at the development of particulate, gastric-resistant pharmaceutical forms, incorporating those bioactive molecules. Mixtures of proteins in powder form were coated with cellulose acetate phthalate, Eudragit® S100 or Eudragit® RS PO, using simple preparation techniques based on single emulsion/solvent evaporation. Using aprotinin as a model drug, it was found that these procedures were effective in microencapsulating protein in the solid form without affecting its biological activity. Furthermore, and in particular with the first two polymers above, particles showed adequate in vitro release patterns for the applications envisioned.
Original languageEnglish
Pages (from-to)39-44
Number of pages6
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Issue number1
Publication statusPublished - 2001


  • Emulsion/solvent evaporation technique
  • Enteric forms
  • Inflammatory conditions of the intestines
  • Microparticles
  • Protein stability
  • Proteolytic degradation


Dive into the research topics of 'Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine'. Together they form a unique fingerprint.

Cite this